签约仪式（苏北人民医院供图） 作为扬州市乃至苏北地区的医疗、科研与教学中心，苏北人民医院长期以来将科技创新与成果转化置于发展核心，在学科建设、技术攻关与平台搭建等方 面取得了系列突破。此次选择与国内医疗器械领域重要的研发制造企业——驼人集团携手，体现了医院以开放姿态整合社会优势资源、破解成果转化瓶颈 的前瞻布局。双方的合作聚焦于联合技术攻关、加速成果转化与复合型人才培养，旨在打通从临床发现问题到产业转化落地的关键链条，构建"临床需求 －研发创新－产业转化"协同发展的"铁三角"模式。这一模式正是响应国家科技自强战略、补齐生物医药领域短板的重要实践，有望显著提升医院自身的 科研创新效率和临床服务能力，推动其向高水平研究型医院目标加速迈进。 此次合作对"健康扬州"建设的积极意义尤为深远。当前，医疗健康领域的竞争日益体现在科技创新与产业融合的深度上。苏北人民医院与驼人集团的强强 联合，是以临床实际需求为导向，推动"产学研医"深度融合的生动典范。扬州市卫生健康委员会与市科学技术局对此给予高度肯定与全力支持，期待其能 为全市医疗卫生系统树立科技成果转化的新标杆。通过院企深度合作，不仅可以加速本土化、高临床价值的创新医疗产 ...

在人工智能发展浪潮下，从加速新药研发进程，到赋能临床精准诊疗，再到驱动医疗产业创新升级，医 工融合正从"单点突破"迈向"全域开花"，为守护人民群众生命健康提供更有力的科技支撑。 更快！有望缩短新药研发周期 新药研发，如同在巨大迷宫中找到一条正确的路径，周期往往极为漫长。能否提升试错效率？AI被寄 予厚望。 日前，我国自主研发的开放式、普惠性AI制药平台——"AI孔明"正式发布。其在疟疾、结核病以及病毒 等全球健康挑战的相关数据库，向全球免费开放。 "该平台已经在数十条真实研发管线中完成系统验证，相较传统流程，候选分子命中率与优化效率实现 了数倍至数十倍的显著提升。"全球健康药物研发中心首席运营官陆漫春说。 研发团队领队、全球健康药物研发中心数据科学部负责人郭晋疆介绍，在"AI孔明"制药平台中，开发了 AI分子设计模型、高精度虚拟筛选、多任务ADMET评估模型等原创算法，覆盖"靶点结构分析、AI分 子生成与优化、活性筛选、成药性评估"全流程，压缩传统药物研发时间。 当AI与医学、工程技术相遇，将会碰撞出哪些火花？ 目前，这项成果已在北京协和医院等地进行临床试验。在AI音律引导下，原本步态僵硬、不协调的患 者，步 ...

新药研发，如同在巨大迷宫中找到一条正确的路径，周期往往极为漫长。能否提升试错效率？AI被寄 予厚望。 日前，我国自主研发的开放式、普惠性AI制药平台——"AI孔明"正式发布。其在疟疾、结核病以及病毒 等全球健康挑战的相关数据库，向全球免费开放。 "该平台已经在数十条真实研发管线中完成系统验证，相较传统流程，候选分子命中率与优化效率实现 了数倍至数十倍的显著提升。"全球健康药物研发中心首席运营官陆漫春说。 研发团队领队、全球健康药物研发中心数据科学部负责人郭晋疆介绍，在"AI孔明"制药平台中，开发了 AI分子设计模型、高精度虚拟筛选、多任务ADMET评估模型等原创算法，覆盖"靶点结构分析、AI分 子生成与优化、活性筛选、成药性评估"全流程，压缩传统药物研发时间。 加速新药智能研发，正是"人工智能+"的一个重要方向。国家卫生健康委等部门2025年公布的《关于促 进和规范"人工智能+医疗卫生"应用发展的实施意见》中，明确提出要开发新药筛选模型。 新华社北京1月5日电 题：AI遇上医疗 健康守护如何注入新活力？ 新华社记者彭韵佳、刘祯 当AI与医学、工程技术相遇，将会碰撞出哪些火花？ 在人工智能发展浪潮下，从加速新药 ...

本次推进会是山东省落实国家药监局"春雨行动"、抢抓医疗器械产业发展机遇的重要举措。活动现场， 山东省医疗器械审评查验中心正式揭牌，标志着全省医疗器械审评查验体系建设取得关键进展，将为产 业创新提供更加有力的支撑和保障。 会议发布了《山东省人民政府办公厅关于深化药品医疗器械监管改革促进医药产业高质量发展的实施意 见》。该文件聚焦产业升级，提出一系列前瞻性政策举措，要求各责任单位加强跨部门协同与会商，建 立健全信息共享机制，确保政策精准落地，为山东医药全产业链创新注入新动能。 会上，"春雨行动"遴选的十大创新成果集中亮相。五家医疗机构与五家优质企业现场签署临床研究成果 转化战略合作协议，推动医工协同进入共研共担、利益共享的实质性合作新阶段。在政策解读与成果分 享环节，国家药监局器审中心专家详细阐释"春雨行动"政策内涵与实施路径；省药监局、省器审中心、 省器械检验院分别围绕创新医疗（002173）器械审评审批、审评检查赋能、检验检测助力医工融合等关 键环节进行解读，系统呈现覆盖研发、验证、注册、生产全生命周期的政策支持体系；医疗机构与企业 代表结合实践案例，分享医工融合与成果转化经验，为行业创新提供有益借鉴。现场交 ...

Core Viewpoint - The integration of medical and engineering fields is becoming a key driver for breakthroughs in high-end medical equipment and biopharmaceutical innovation, particularly in Zhuhai, which is positioned as a strategic hub in the Guangdong-Hong Kong-Macao Greater Bay Area [2]. Event Details - The "Medical-Engineering Integration Annual Conference 2025" will be held from December 26 to 28, 2025, in Zhuhai, Guangdong, aiming to promote high-quality development in the medical-engineering integration sector [2]. - The conference theme is "Jointly Inviting the Bay Area: Medical-Engineering Integration to Inspire the Future," focusing on creating a resource platform for collaboration among government, associations, hospitals, universities, research institutions, investment entities, and enterprises [2]. Organizing Institutions - The conference is guided by the China Medical and Health Culture Association and organized by Beijing Institute of Technology (Zhuhai), Zhuhai Health Bureau, and the Medical-Engineering Integration Branch of the China Medical and Health Culture Association [3]. Conference Highlights - The event will feature top scholars and industry leaders sharing insights on cutting-edge research and industry trends, fostering a collaborative ecosystem for project signing and talent introduction [60]. - A dedicated Zhuhai Medical-Engineering Integration Liaison Office will be established to provide ongoing support and services, including policy consultation and funding connections [60]. Main Content - The agenda includes leadership speeches, high-quality thematic forums, academic dialogues, and an award ceremony for outstanding orthopedic innovation projects [61]. - Resource matching sessions will be organized, including project roadshows and expert evaluations, along with site visits to local leading enterprises [61]. - Policy and service promotion will cover key industry policies in biomedicine, high-end medical equipment, and artificial intelligence [61].

Core Viewpoint - The article discusses the significant advancement in gastrointestinal endoscopy technology with the introduction of a domestic high-definition endoscope system combined with AI-assisted diagnostic capabilities in Xinjiang, China. This innovation aims to enhance the accuracy and efficiency of gastrointestinal disease screening and treatment in county-level medical settings, reducing the need for patients to travel to larger hospitals for care [1]. Part 1: Clinical Demand Discovery - The emergence of the AI-assisted gastrointestinal endoscopy system is driven by unmet clinical needs, particularly the challenge of early detection of small lesions in gastrointestinal cancer patients, which often leads to late-stage diagnoses [3][4]. - The system enhances lesion recognition, operational standardization, and diagnostic reliability through a collaborative approach involving doctors, equipment, and AI [5]. Part 2: Technical Solution Selection - Various technical paths were considered for the AI-assisted gastrointestinal endoscopy system, including software enhancements to existing equipment, hardware upgrades for improved imaging, and a combination of both [6][7]. - Path A focuses on adding AI capabilities to existing endoscope systems, exemplified by the GI Genius system, which has shown a 14.4% increase in adenoma detection rates [8]. - Path B involves upgrading hardware for better imaging quality, while Path C emphasizes a gradual approach starting with quality control before expanding to lesion detection [10][11]. Part 3: Cross-Disciplinary Team Collaboration - The development phase involves a collaborative ecosystem where algorithm engineers, hardware engineers, and clinical doctors work together to refine the AI system based on real-world clinical practices [14]. - Iterative prototyping and preclinical validation are crucial, with multiple stages of testing to ensure safety and effectiveness before clinical trials [15][16]. Part 4: Clinical Trials and Regulatory Approval - Clinical trials are essential for validating the safety and effectiveness of the AI-assisted endoscopy system, with early studies indicating significant improvements in adenoma detection rates [20][21]. - Regulatory bodies like the FDA and NMPA play a critical role in the approval process, focusing on the system's effectiveness, safety, and compatibility with existing medical devices [23][24]. Part 5: Productization and Clinical Application - After regulatory approval, the AI endoscopy product enters the commercialization phase, requiring adaptation to various hospital systems and ensuring compliance with medical device standards [30]. - Key players in this phase include manufacturing, marketing, and clinical support teams, with a focus on demonstrating clinical efficacy to encourage adoption [31]. Challenges and Key Factors - The commercialization process faces challenges such as high initial costs, skepticism from experienced doctors, and the need for standardized protocols to ensure consistent performance across different products [34][35]. - Long-term success in the market will depend on continuous innovation, collaboration within the industry, and the ability to demonstrate tangible clinical benefits to both doctors and patients [36].

Core Viewpoint - The successful launch of the "Yixian-A Star," the world's first satellite to conduct in-orbit verification of wooden outer panels, marks a significant achievement in space technology and innovation led by a team of young researchers from Sun Yat-sen University [1][5]. Group 1: Development and Innovation - The "Yixian-A Star" was developed by a team primarily composed of nine young members, with postdoctoral researcher Wang Hui as the team leader, who has pursued his dream of space exploration for 22 years [1][2]. - The satellite serves as a platform for scientific experiments, technology validation, and educational training, focusing on innovative materials to address space debris and atmospheric pollution [3]. - The team faced significant challenges due to the extreme conditions of space, including temperature fluctuations, vacuum, and radiation, which posed risks to material stability [3]. Group 2: Research and Collaboration - Wang Hui established the Micro-Nano Satellite Association at Sun Yat-sen University in 2021, which formalized the "satellite-making" initiative [3]. - The team collaborated with various departments, including materials science and advanced manufacturing, to explore different types of wood and processing techniques to enhance the durability of wooden materials for space [3]. Group 3: Launch and Future Plans - The "Yixian-A Star" was successfully launched on December 10, 2023, and is set to operate in space for six months, conducting tasks such as satellite imaging, testing the wooden outer panel, and validating software-defined satellite technologies [5][8]. - Following the success of "Yixian-A Star," the team is already working on the next satellite in the series, "Yixian-B," aiming for breakthroughs in fields like medical engineering [8].

由眼未来主办的 第二届全球眼科大会（Global Ophthalmology Conference 2026） 将于 2026年3月19日 在北京 中关村展示中心 举办。 本届大会延续 "医工融合 × 科技创新 × 临床价值" 的整体定位，聚焦眼科成像、屈光与近视、创新治疗、手术技术、临床前验证等多领域趋势，呈现眼科产 业科技的前沿全景。 大会同期开放 「2026全球眼科年度奖项」申报及《全球眼科创新白皮书》联合撰写席位 ，诚邀各方团队共筑权威成果、共享国际平台。 首届眼科大会回顾 报名方式见以下链接： 奖项申报通知！第二届全球眼科大会 白皮书合作 | 《2026全球眼科创新白皮书》共建计划 大会亮点概览 首届眼科大会回顾 会场与展区 年度白皮书发布： 大会现场发布 《2026全球眼科创新白皮书》 。 奖项盛典： 颁发 "眼科创新系列大奖" ，树立行业标杆，让创新被看见。 精品展位与深度互动： 会场核心区设有 精品展位 ，为赞助商提供与全场高质量决策者面对面洽谈、产品演示与合作签约的高效平台。 创新Demo Hour： 十余家精选创新团队进行 5–10分钟 高密度路演 ，直击投资与合作需求，打造前沿技术首发阵 ...

各位专家学者，朋友们: 会议主题 02 本次大会以" 京珠共邀汇湾区·医工融合启未来 "为主题，旨在搭建一个汇聚政府、协会、医院、高校、科研机构、 投融资机构及企业的全方位资源对接平台，推动医工融合在生物医药、智能诊疗、手术机器人、AI内镜、微纳材料、数 字疗法等前沿领域的深度合作与成果转化。 会议组织机构 03 指导单位： 中国医药卫生文化协会 主办单位： 北京理工大学（珠海） 中国医药卫生文化协会医工融合分会 联合主办： 广东真健康医疗科技开发股份有限公司 在"健康中国2030"战略的引领下，医工融合正成为驱动高端医疗装备自主突破、生物医药创新发展、催 生新质生产力的关键引擎。珠海，作为粤港澳大湾区战略支点，叠加"三区"政策红利，已汇聚高端人才、顶尖 医疗、科研与产业资源，具备打造国家级医工融合高地的独特优势。 为积极响应广东省打造万亿级生物医药与健康产业集群的战略部署，促进粤港澳大湾区医工融合高质量 发展，在中国医药卫生文化协会指导下，中国医药卫生文化协会医工融合分会联合北京理工大学、北京理工大 学（珠海）、珠海市人民医院等机构，定于 2025年12月26日(周五)至28日(周日) ，在 广东·珠海 隆 ...

Core Viewpoint - The successful launch of the "Yixian-A" satellite, developed by a student team from Sun Yat-sen University, marks a significant achievement in the field of aerospace engineering and education, showcasing the university's commitment to new engineering disciplines and talent cultivation [1][3]. Group 1 - The "Yixian-A" satellite was launched on December 10, 2023, at 12:03 PM from the Jiuquan Satellite Launch Center using the Kuaizhou-1A rocket, successfully entering its designated orbit at 12:17 PM [1]. - The satellite is the world's first to conduct in-orbit verification of wooden outer panels, demonstrating innovative materials in aerospace applications [1][3]. - The satellite is designed for a six-month mission, focusing on tasks such as satellite imaging, wooden outer panel testing, and software-defined satellite technology validation using Raspberry Pi [3]. Group 2 - The development of "Yixian-A" took four years, involving multiple iterations and significant support from the university, alumni, and various academic disciplines, including aerospace, materials, and advanced manufacturing [3]. - The student team plans to continue developing the "Yixian" series of satellites, aiming for innovative breakthroughs in fields such as medical engineering integration [3].